The Lyra Direct SARS-CoV-2 Assay was designed for molecular detection of Covid-19. Credit: Louis Reed / Unsplash.

Quidel has received EUA from the US Food and Drug Administration (FDA) for the Lyra Direct SARS-CoV-2 Assay to allow direct Covid-19 test sample processing.

The assay was designed for molecular detection of Covid-19.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

According to the new EUA, the Lyra Direct SARS-CoV-2 removes RNA extraction processing step and supply bottleneck and no longer requires an upfront sample extraction.

A reformulated buffer used by the assay replaces the extraction step with a simple heat step that takes ten minutes.

The Lyra Direct SARS-CoV-2 Assay retains its versatility and can run on any of seven possible thermocyclers.

The thermocyclers include Applied Biosystems 7500 Standard, Applied Biosystems 7500 Fast, Bio-Rad CFX96 Touch, Qiagen Rotor-Gene Q, Roche LightCycler 480, Roche Cobas z480 and Thermo Fisher QuantStudio 7 Pro.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Additionally, the Lyra Direct assay has received CE Mark, which allows Quidel to market and sell it in Europe and other countries where CE Mark is accepted.

Currently, the test is available for sale in the US under EUA. Laboratory professionals can buy the assay through Quidel directly or through its Cardinal Health representative.

The latest development comes after the FDA granted expanded EUA for the Lyra SARS-CoV-2 Assay for Covid-19 diagnosis. It will enable testing with three additional thermocyclers – Applied Biosystems 7500 Standard, Roche LightCycler 480 and Qiagen Rotor-Gene Q.

Last week, Quidel received EUA from the FDA to market its Sofia 2 SARS Antigen FIA, a rapid, point-of-care test to diagnose Covid-19. It will be used with Sofia 2 Fluorescent Immunoassay Analyser for rapid detection of SARS-CoV-2 virus in nasal or nasopharyngeal specimens from patients with symptoms of the virus.